Dr. Lauren Skelly is a Senior Scientist in the Translational Research group at the Gene Editing Institute. Lauren received her PhD in 2022 from the University of Maryland, College Park. During her doctoral research, she studied the evolutionary basis of phenotypic novelties through protein-protein and protein-RNA interactions and explored DNA editing and RNA labeling. She then joined the FDA Center for Biologics Evaluation and Research (CBER) as a contract research scientist to study novel gene editing technologies before moving to GEI in 2024. At GEI, Lauren focuses on the functional outcomes of NRF2 targeting and applies evolutionary and population genetics frameworks to CRISPR gene editing.
